Disease

Science's war against the super-small and, sometimes, super-deadly bacteria that have evolved to resist destruction by antibiotics may have just enlisted new, unlikely allies: invertebrate creatures living in the frigid depths of the Arctic Ocean.

If you're getting plenty of leafy greens, dark chocolate, nuts, and beans, you're probably doing fine. But if your diet is lacking, you might want to pay attention to this new eye-opening study that links a mineral deficiency issue to DNA changes.

In a completely different kind of germ warfare, researchers have tested out a way to drop mosquitoes infected with disease-fighting bacteria over populations prone to outbreaks of dengue fever. It's an ingenious way to scale up a proven solution.

Scientists are again on high alert, as whole genome sequencing of the H5N1 virus has revealed that it is capable of multidirectional infections across species. While human risk is low, it's a step forward for the pathogen in this biological arm's race.

A new gene therapy for Duchenne muscular dystrophy (DMD) has shown promise in not only slowing the progression of the disease but potentially even reversing the muscle damage, with human trials set to begin within two years.

To Brie or not to Brie: A massive study of 2.3 million people has found that mental well-being may be the most important aspect to healthy aging and living longer. And, surprisingly, eating more cheese had a rather interesting impact on the results.

New research uncovering the DNA-damaging mechanism by which a mutated gene causes a rare, fatal disease may have repercussions for the treatment of many other diseases linked to aging, including heart disease, autoimmune disorders, and cancer.

A study has found that having two APOE4 genes may not just be a risk factor in Alzheimer's disease, but a driver of it. Nearly all carriers' brains showed key disease biomarkers by age 65, suggesting it may instead be a type of inheritable Alzheimer's.

California-based biopharmaceutical company Rubedo Life Sciences has announced that thanks to US$40 million in financial backing, it can commence human trials of its drug RLS-1469, designed to target the senescent cells that cause age-related disease.

The four spikes on a new nanocrystal developed in Spain spin up under light and move through liquid, blasting any bacteria unfortunate to be in their path. The development could spell trouble for bacteria that resists traditional drug treatments.

As common as asthma is, exactly how it starts remains murky. Scientists have now identified a new root cause, and importantly a new angle for treating the disease that can prevent the main symptoms.

When it comes to toilet etiquette, do you put the lid down before you flush, or leave it up? A new study has shown just what happens when you leave it up – and the results might have you questioning just what you do behind closed doors.